RhythmScience has filed a notice of an exempt offering of securities to raise $7,500,000.00 in New Equity Investment.
According to filings with the U.S. Securities and Exchange Commission, RhythmScience is raising $7,500,000.00 in new funding. Sources indicate that as part of senior management Chief Executive Officer, Shawn Kumar played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.
About RhythmScience
RhythmScience is a California-based software development company and Independent Diagnostic Testing Facility credentialed by Medicare. We created RhythmScience to solve the need of clinicians and doctors to manage the vast amounts of cardiac data created by implantable and wearable cardiac devices. RhythmScience is revolutionizing cardiac data by providing the building blocks for comprehensive remote cardiac care.
To learn more about RhythmScience, visit http://rhythm360.io/
Contact:
Shawn Kumar, Chief Executive Officer
844-420-0024
SOURCE: http://www.intelligence360.io
Copyright (c) 2023 SI360 Inc. All rights reserved.